4.5 Article

RAMIHM generates fully human monoclonal antibodies by rapid mRNA immunization of humanized mice and BCR-seq

期刊

CELL CHEMICAL BIOLOGY
卷 30, 期 1, 页码 85-+

出版社

CELL PRESS
DOI: 10.1016/j.chembiol.2022.12.005

关键词

-

向作者/读者索取更多资源

As a clinical vaccine, lipid nanoparticle (LNP) mRNA has shown strong antibody responses and potential for antibody discovery. A strategy called RAMIHM, which combines rapid mRNA immunization of humanized mice with single B cell sequencing (scBCR-seq), was developed to efficiently generate fully human monoclonal antibodies. RAMIHM was used to immunize humanized transgenic mice and successfully generated highly specific antibodies against antigens. This strategy was also extended to cancer immunotherapy targets, demonstrating its broad applicability in antibody development.
As a clinical vaccine, lipid nanoparticle (LNP) mRNA has demonstrated potent and broad antibody re-sponses, leading to speculation about its potential for antibody discovery. Here, we developed RAMIHM, a highly efficient strategy for developing fully human monoclonal antibodies that employs rapid mRNA immu-nization of humanized mice followed by single B cell sequencing (scBCR-seq). We immunized humanized transgenic mice with RAMIHM and generated 15 top-ranked clones from peripheral blood, plasma B, and memory B cell populations, demonstrating a high rate of antigen-specificity (93.3%). Two Omicron-specific neutralizing antibodies with high potency and one broad-spectrum neutralizing antibody were discovered. Furthermore, we extended the application of RAMIHM to cancer immunotherapy targets, including a single transmembrane protein CD22 and a multi-transmembrane G protein-coupled receptor target, GPRC5D, which is difficult for traditional protein immunization methods. RAMIHM-scBCR-seq is a broadly applicable platform for the rapid and efficient development of fully human monoclonal antibodies against an assortment of targets.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据